Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601–615 (2021).
Choutka, J., Jansari, V., Hornig, M. & Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med. 28, 911–923 (2022).
Narasimhan, H., Wu, Y., Goplen, N. P. & Sun, J. Immune determinants of chronic sequelae after respiratory viral infection. Sci. Immunol. 7, eabm7996 (2022).
Cheon, I. S. et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci. Immunol. 6, eabk1741 (2021).
Vijayakumar, B. et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity 55, 542–556 (2022).
Phetsouphanh, C. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210–216 (2022).
Jyothula, S. S. K. et al. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation. eBioMedicine 86, 104351 (2022).
Gagiannis, D. et al. Clinical, imaging, and histopathological features of pulmonary sequelae after mild COVID-19. Am. J. Respir. Crit. Care Med. 208, 618–621 (2023).
Yao, C. et al. Maladaptive TGF-β signals to the alveolar epithelium drive fibrosis after COVID-19 infection. Am. J. Respir. Crit. Care Med. 208, 201–204 (2023).
Xie, Y., Choi, T. & Al-Aly, Z. Association of treatment with nirmatrelvir and the risk of post–COVID-19 condition. JAMA Intern. Med. 183, 554–564 (2023).
Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259–264 (2021).
Bharat, A. et al. Lung transplantation for patients with severe COVID-19. Sci. Transl. Med. 12, eabe4282 (2020).
Stewart, I. et al. Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD Post-COVID-19 Study. Am. J. Respir. Crit. Care Med. 207, 693–703 (2022).
Bowe, B., Xie, Y. & Al-Aly, Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 29, 2347–2357 (2023).
Merad, M., Blish, C. A., Sallusto, F. & Iwasaki, A. The immunology and immunopathology of COVID-19. Science 375, 1122–1127 (2022).
Bingham, G. C. et al. High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis. Front. Immunol. 14, 1308594 (2024).
Arish, M., Qian, W., Narasimhan, H. & Sun, J. COVID-19 immunopathology: from acute diseases to chronic sequelae. J. Med. Virol. 95, e28122 (2023).
Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139–148 (2023).
Vaughan, A. E. et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature 517, 621–625 (2015).
Kobayashi, Y. et al. Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis. Nat. Cell Biol. 22, 934–946 (2020).
Strunz, M. et al. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis. Nat. Commun. 11, 3559 (2020).
Choi, J. et al. Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration. Cell Stem Cell 27, 366–82 (2020).
Kumar, P. A. et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147, 525–538 (2011).
Xie, T. et al. Abnormal respiratory progenitors in fibrotic lung injury. Stem Cell Res. Ther. 13, 64 (2022).
Habermann, A. C. et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci. Adv. 6, eaba1972 (2020).
Adams, T. S. et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci. Adv. 6, eaba1983 (2020).
Rendeiro, A. F. et al. Persistent alveolar type 2 dysfunction and lung structural derangement in post-acute COVID-19. Preprint at medRxiv https://doi.org/10.1101/2022.11.28.22282811 (2022).
Jiang, P. et al. Ineffectual type 2-to-type 1 alveolar epithelial cell differentiation in idiopathic pulmonary fibrosis: persistence of the KRT8hi transitional state. Am. J. Respir. Crit. Care Med. 201, 1443–1447 (2020).
Tsukui, T. et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat. Commun. 11, 1920 (2020).
Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070–1085 (2020).
Dinnon, K. H. et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci. Transl. Med. 14, eabo5070 (2022).
Goplen, N. P. et al. Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia. Sci. Immunol. 5, eabc4557 (2020).
Dinnon, K. H. et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560–566 (2020).
Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327–1335 (2020).
Wei, X., Narasimhan, H., Zhu, B. & Sun, J. Host recovery from respiratory viral infection. Ann. Rev. Immunol. 41, 277–300 (2023).
Wang, F. et al. Regulation of epithelial transitional states in murine and human pulmonary fibrosis. J. Clin. Invest. 133, e165612 (2023).
Liang, J. et al. Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis. eLife 12, e85415 (2023).
D’Agnillo, F. et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci. Transl. Med. 13, eabj7790 (2021).
Melms, J. C. et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114–119 (2021).
Konkimalla, A. et al. Transitional cell states sculpt tissue topology during lung regeneration. Cell Stem Cell 30, 1486–502 (2023).
Fiege, J. K. & Langlois, R. A. Investigating influenza A virus infection: tools to track infection and limit tropism. J. Virol. 89, 6167–6170 (2015).
Katsura, H., Kobayashi, Y., Tata, P. R. & Hogan, B. L. M. IL-1 and TNFα contribute to the inflammatory niche to enhance alveolar regeneration. Stem Cell Rep. 12, 657–666 (2019).
Kostura, M. J. et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc. Natl Acad. Sci. USA 86, 5227–5231 (1989).
Littlefield, K. M. et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 18, e1010359 (2022).
Krishna, B. A. et al. Spontaneous, persistent, T cell-dependent IFN-γ release in patients who progress to long COVID. Sci. Adv. 10, eadi9379 (2024).
Riemondy, K. A. et al. Single cell RNA sequencing identifies TGFβ as a key regenerative cue following LPS-induced lung injury. JCI Insight 5, e123637 (2019).
Nabhan, A. N., Brownfield, D. G., Harbury, P. B., Krasnow, M. A. & Desai, T. J. Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells. Science 359, 1118–1123 (2018).
Salama, C. et al. Tocilizumab in patients hospitalized with COVID-19 pneumonia. N. Engl. J. Med. 384, 20–30 (2020).
Stancil, I. T. et al. Interleukin-6-dependent epithelial fluidization initiates fibrotic lung remodeling. Sci. Transl. Med. 14, eabo5254 (2022).
Choi, J. et al. Release of Notch activity coordinated by IL-1β signalling confers differentiation plasticity of airway progenitors via Fosl2 during alveolar regeneration. Nat. Cell Biol. 23, 953–966 (2021).
Chen, B., Julg, B., Mohandas, S., Bradfute, S. B. & Force RMPT. Viral persistence, reactivation, and mechanisms of long COVID. eLife 12, e86015 (2023).
Proal, A. D. et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat. Immunol. 24, 1616–1627 (2023).
An EUA for baricitinib (olumiant) for COVID-19. Med. Lett. Drugs Ther. 62, 202–203 (2020).
An EUA for anakinra (kineret) for COVID-19. Med. Lett. Drugs Ther. 64, e203 (2022).
Goplen, N. et al. Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma. J. Allerg. Clin. Immunol. 123, 925–932 (2009).
Major, J. et al. Endothelial AHR activity prevents lung barrier disruption in viral infection. Nature 621, 813–820 (2023).
Weiner, A. I. et al. ΔNp63 drives dysplastic alveolar remodeling and restricts epithelial plasticity upon severe lung injury. Cell Rep. 41, 111805 (2022).
Huang, S. et al. PPAR-γ in macrophages limits pulmonary inflammation and promotes host recovery following respiratory viral infection. J. Virol. 93, e00030-19 (2019).
Hübner, R. H. et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 44, 507–511 (2008).
Wong, L.-Y. R. et al. Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19. Nature 605, 146–151 (2022).
Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
More News
Mosquito-borne diseases are surging in Europe — how worried are scientists?
Islands are rich with languages spoken nowhere else
I fire darts at whales to help track their movements